Sartorius | SRT3 - Ordinary Share Capital

Stock Price
217.10
Daily Change
2.20 1.02%
Monthly
0.74%
Yearly
-3.12%
Q2 Forecast
211.39

Sartorius reported EUR69.05M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Akebia Therapeutics USD 265.42M 199K Dec/2025
Alaunos Therapeutics USD 2.21M 131K Sep/2025
Dianthus Therapeutics USD 43.22M 368.53K Dec/2025
Ionis Pharmaceuticals USD 161.97M 836K Dec/2025
IQVIA Holdings USD 169.6M 700K Dec/2025
Moderna USD 391M 2M Sep/2025
Organon & Co USD 259.98M 18K Sep/2025
Revvity USD 113.38M 2.7M Dec/2025
Sartorius EUR 69.05M 0 Mar/2026
Tectonic Therapeutic USD 18.74M 25.03K Dec/2025
Viatris USD 1.16B 6.55M Sep/2025
Xeris Pharmaceuticals USD 166.22M 687.16K Dec/2025